Valeo Ventures is a corporate venture capital firm focused on healthcare innovation, partnering with health plans and hospital systems to drive strategic and financial returns through venture investment.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Valeo Ventures is dedicated to catalyzing healthcare innovation by fostering collaboration between healthcare leaders and entrepreneurs. Founded with over 25 years of experience in venture capital and operational management, Valeo aims to address challenges within the healthcare system through strategic partnerships and capital investment. The firm combines institutional-grade investment practices with deep strategic engagement, focusing on enhancing the ability of its partners to achieve both near-term strategic ROI and long-term investment returns. Valeo Ventures operates as the exclusive investment manager for Cobalt Ventures, the corporate venture capital arm of Blue Cross and Blue Shield of Kansas City, emphasizing its commitment to the healthcare sector.
Valeo Ventures focuses on investing in healthcare innovation by connecting leaders with entrepreneurial solutions. Their approach combines institutional-grade investment practices with deep strategic engagement, aiming to drive value for stakeholders and enhance the ability of partners to achieve both near-term strategic ROI and long-term investment returns.
Valeo Ventures adds value to its portfolio companies by leveraging its extensive network within the healthcare sector, providing strategic engagement, and facilitating partnerships that enhance operational efficiencies and market access.
Valeo Ventures focuses exclusively on healthcare innovation, seeking startups that can connect entrepreneurial solutions with industry leaders. They look for companies that demonstrate a clear understanding of the healthcare landscape and present innovative solutions to existing challenges.
Founders interested in pitching to Valeo Ventures should visit their website at valeovc.com for more information on the application process. They emphasize the importance of demonstrating both strategic vision and operational feasibility in pitches.
Valeo Ventures distinguishes itself through its exclusive focus on healthcare innovation and its commitment to strategic engagement. The firm combines institutional-grade investment practices with deep industry insights, providing valuable support to its portfolio companies.
While specific geographic preferences are not detailed, Valeo Ventures is primarily focused on the healthcare sector, suggesting a likely emphasis on markets where healthcare innovation is critical.
Valeo Ventures provides operational support and strategic insights to its portfolio companies, leveraging its extensive experience in venture capital and healthcare management to enhance their partners' capabilities.
Specific check size ranges are not disclosed, but Valeo Ventures employs institutional-grade investment practices, indicating a professional approach to funding that aligns with industry standards.
Organizations that do similar work to Valeo Ventures.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorNueterra Capital is a Midwest-based venture capital firm that invests in early-stage healthcare and technology companies. Founded in 1997, it focuses on innovative firms in U.S. Emerging Markets.
InvestorOrbiMed is a healthcare-focused investment firm based in New York City, managing approximately $19 billion in assets. The firm invests across the healthcare spectrum, from early-stage startups to large multinational companies, with a focus on biopharmaceuticals and medical technologies.
Superscout Pro
Is this page right?Reviewed · How the research works